查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1755859

2032 年免疫测量市场预测：按产品类型、平台、技术、检体类型、应用、最终用户和地区进行的全球分析

Immunoassay Market Forecasts to 2032 - Global Analysis By Product Type (Reagents & Kits, Analyzers, Software & Services, and Other Product Types), Platform, Technology, Specimen Type, Application, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球免疫测量市场预计在 2025 年达到 407.4 亿美元，到 2032 年将达到 693.8 亿美元，预测期内的复合年增长率为 7.9%。

免疫测量是一种利用抗原抗体反应来测量液体样本中某种物质的存在或浓度的生化检测方法。免疫测定广泛应用于诊断、药物研究和环境检测，以检测荷尔蒙、药物、蛋白质和病原体。免疫测量具有较高的敏感度和特异性，使其成为疾病诊断、治疗药物监测和生物医学研究应用的重要工具。

根据国发会预估，2025年台湾老龄人口比将达19.9%，2030年将达23.9%，2035年将达27.3%。

慢性病增多

癌症、心血管疾病和自体免疫疾病等慢性疾病的增加推动了免疫测量检测的需求。免疫测量在疾病诊断、监测和治疗管理中发挥至关重要的作用，并广泛应用于临床。此外，检测技术的进步提高了灵敏度和特异性，增强了其在诊断实验室中的应用。人口老化和感染疾病病率的上升进一步促进了市场扩张。

设备和试剂高成本

先进的检测系统需要高昂的前期投资，这阻碍了中小型医疗保健机构采用这些技术。试剂和耗材的经常性支出推高了整体营运成本，并限制了其可近性，尤其是在新兴经济体。此外，严格的监管标准要求昂贵的验证流程，这增加了製造商的财务负担。成本限制也阻碍了自动化免疫测量设备在资源有限的医疗保健机构中的广泛应用。

POC 侦测需求

POC免疫测量係统能够快速且准确地诊断疾病，从而促进及时的医疗干预。由于其便捷高效，POC检测在医院、诊所和家庭医疗保健机构的应用日益广泛。可携式免疫测量设备的技术进步提高了其可近性，尤其是在偏远和服务不足的地区。人们对疾病早期检测意识的不断提高，进一步推动了POC免疫测量测定仪器的需求。市场参与企业正在投资技术创新，以开发用户友好且经济高效的POC检测解决方案。

标准化有限

检测表现的差异会导致诊断结果的差异，并影响临床决策。实验室和医疗保健机构在整合不同製造商的免疫测量系统时，面临互通性问题。缺乏普遍接受的测量方案使品管变得复杂，并引发了对检测可靠性的担忧。儘管监管机构强调标准化，但不同技术之间的协调仍然难以实现。

COVID-19的影响

由于对快速且准确的诊断检测需求的迫切，COVID-19 疫情极大地推动了免疫测量市场的发展。用于检测和监测病毒的抗体和抗原检测需求激增，刺激了技术创新和产能提升。各国政府和医疗机构在诊断领域投入巨资，扩大了市场规模，并加快了监管核准。疫情过后，人们对感染疾病的认识不断提高，并为未来的疫情爆发做好了准备，这推动了免疫测量领域的持续成长和技术进步。

试剂和套件部分预计将成为预测期内最大的部分

由于试剂和套件盒在免疫测量测定检测程序中发挥关键作用，预计将在预测期内占据最大的市场占有率。医院、诊断实验室和研究机构的高试剂消耗率促成了该细分市场的巨大份额。全球诊断检测数量的增加推动了对免疫测量测定试剂的需求。试剂配方的不断改进提高了检测灵敏度，从而促进了其广泛应用。

预测期内，医院和诊所部门的复合年增长率最高

由于患者人数不断增加且诊断需求不断增长，预计医院和诊所细分市场将在预测期内实现最高增长率。免疫测量方法在医院广泛用于疾病筛检、治疗监测和紧急诊断。医院实验室正在采用自动化免疫测量分析仪，以提高效率和准确性。医疗保健投资的不断增长以及对高通量检测解决方案的需求正在推动市场扩张。

最大份额区域：

在预测期内，由于医疗保健行业的快速发展，预计亚太地区将占据最大的市场占有率。政府对医疗基础设施的持续投资，推动了中国、印度和日本等主要国家的市场成长。人们对疾病早期诊断和预防意识的不断提高，推动了免疫测量方法的采用。感染疾病和慢性病的盛行率上升，也加速了先进诊断解决方案的需求。

复合年增长率最高的地区：

由于拥有先进的医疗基础设施和强有力的法律规范，预计北美地区在预测期内的复合年增长率最高。大型诊断公司和研究机构的存在正在加速免疫测量技术的创新。医疗支出的增加和政府对精准医疗的支持措施正在推动市场扩张。慢性病负担的加重以及对早期诊断解决方案的需求正在推动免疫测量的普及。

免费客製化服务：

订阅此报告的客户将获得以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的SWOT分析（最多3家公司）
  • 地理细分
    • 根据客户兴趣对主要国家市场进行估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球免疫测量市场（依产品类型）

  • 试剂和套件
    • ELISA套件
    • 快速检测套组
    • 蛋白质印迹试剂套件
    • PCR试剂套件
  • 分析仪
    • 开放式系统
    • 封闭式系统
  • 软体和服务
    • 资料管理软体
    • 维护服务
    • 检验和客製化服务
  • 其他产品类型

6. 全球免疫测量市场（依平台）

  • 基于实验室
  • 照护现场检验 (POC)

7. 全球免疫测量市场（依技术）

  • 酵素免疫测量（ELISA）
  • 化学冷光免疫测量（CLIA）
  • 萤光免疫测量（FIA）
  • 免疫测量（RIA）
  • 横向流动化验
  • 其他技术

8. 全球免疫测量市场（依检体类型）

  • 血
  • 尿
  • 唾液
  • 其他检体

第九章全球免疫测量市场（按应用）

  • 感染疾病
  • 治疗药物监测
  • 肿瘤学
  • 自体免疫疾病
  • 心臟病学
  • 内分泌学
  • 其他用途

第 10 章。全球免疫测量市场（按最终用户划分）

  • 医院和诊所
  • 诊断实验室
  • 学术研究所
  • 製药和生物技术公司
  • 血库
  • 居家照护环境
  • 其他最终用户

第 11 章。按地区分類的全球免疫测量市场

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十二章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十三章 公司概况

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • bioMerieux SA
  • DiaSorin SpA
  • Becton, Dickinson and Company（BD）
  • Sysmex Corporation
  • Bio-Rad Laboratories, Inc.
  • QuidelOrtho Corporation
  • PerkinElmer Inc.
  • QIAGEN NV
  • Merck KGaA
  • Fujirebio, Inc.
Product Code: SMRC29753

According to Stratistics MRC, the Global Immunoassay Market is accounted for $40.74 billion in 2025 and is expected to reach $69.38 billion by 2032 growing at a CAGR of 7.9% during the forecast period. An immunoassay is a biochemical test that measures the presence or concentration of a substance, typically in a liquid sample, using the reaction between an antigen and an antibody. It is widely used in diagnostics, pharmaceutical research, and environmental testing to detect hormones, drugs, proteins, or pathogens. Immunoassays offer high sensitivity and specificity, making them essential tools in disease diagnosis, therapeutic drug monitoring, and biomedical research applications.

According to the National Development Council, the geriatric population of Taiwan will reach 19.9% in 2025, 23.9% in 2030, and 27.3% in 2035.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

The increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and autoimmune conditions is driving demand for immunoassay testing. Immunoassays play a crucial role in disease diagnosis, monitoring, and treatment management, leading to their widespread adoption in clinical settings. Additionally, advancements in assay technologies have improved sensitivity and specificity, enhancing their application in diagnostic laboratories. The aging population and rising incidence of infectious diseases further contribute to market expansion.

Restraint:

High cost of instruments and reagents

High initial investment requirements for advanced assay systems deter small and medium healthcare providers from adopting these technologies. The recurring expenses of reagents and consumables add to the overall operational cost, limiting accessibility, particularly in developing economies. Additionally, stringent regulatory standards necessitate expensive validation processes, increasing financial burden on manufacturers. Cost constraints also hinder widespread adoption of automated immunoassay analyzers in resource-limited healthcare settings.

Opportunity:

Point-of-Care testing demand

POC immunoassay systems enable rapid and accurate disease diagnosis, facilitating timely medical intervention. The convenience and efficiency of POC testing are driving adoption across hospitals, clinics, and home healthcare settings. Technological advancements in portable immunoassay devices are enhancing accessibility, especially in remote and underserved regions. Rising awareness regarding early disease detection is further boosting demand for POC immunoassays. Market participants are investing in innovation to develop user-friendly and cost-effective POC testing solutions.

Threat:

Limited standardization

Variability in assay performance can lead to inconsistencies in diagnostic results, affecting clinical decision-making. Laboratories and healthcare providers struggle with interoperability issues when integrating immunoassay systems from different manufacturers. The absence of universally accepted assay protocols complicates quality control efforts, raising concerns about test reliability. Regulatory bodies emphasize standardization, but achieving harmonization across diverse technologies remains complex.

Covid-19 Impact

The COVID-19 pandemic significantly boosted the immunoassay market due to the urgent need for rapid and accurate diagnostic testing. Demand surged for antibody and antigen tests to detect and monitor the virus, driving innovation and increased production capacity. Governments and healthcare organizations invested heavily in diagnostics, expanding market size and accelerating regulatory approvals. Post-pandemic, the heightened awareness of infectious diseases and preparedness for future outbreaks continue to sustain growth and technological advancement in the immunoassay sector.

The reagents & kits segment is expected to be the largest during the forecast period

The reagents & kits segment is expected to account for the largest market share during the forecast period, due to its critical role in immunoassay testing procedures. High consumption rates of reagents in hospitals, diagnostic laboratories, and research institutions contribute to its significant market share. The rising number of diagnostic tests globally is increasing the demand for immunoassay reagents. Continuous advancements in reagent formulations are improving assay sensitivity, fuelling their widespread adoption.

The hospitals & clinics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospitals & clinics segment is predicted to witness the highest growth rate, driven by increasing patient volumes and diagnostic needs. Immunoassays are widely used in hospitals for disease screening, therapeutic monitoring, and emergency diagnostics. The integration of automated immunoassay analyzers in hospital laboratories is improving efficiency and accuracy. Rising healthcare investments and the demand for high-throughput testing solutions are propelling market expansion.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to its rapidly expanding healthcare sector. Increasing government investments in medical infrastructure are fuelling market growth across key countries such as China, India, and Japan. Rising awareness regarding early disease diagnosis and prevention is driving immunoassay adoption. The growing prevalence of infectious and chronic diseases is accelerating demand for advanced diagnostic solutions.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to its advanced healthcare infrastructure and strong regulatory framework. The presence of leading diagnostic companies and research institutions accelerates innovation in immunoassay technologies. Increasing healthcare expenditure and government initiatives supporting precision medicine are driving market expansion. The rising burden of chronic diseases and demand for early diagnostic solutions are fuelling immunoassay adoption.

Key players in the market

Some of the key players profiled in the Immunoassay Market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific Inc., bioMerieux SA, DiaSorin S.p.A., Becton, Dickinson and Company (BD), Sysmex Corporation, Bio-Rad Laboratories, Inc., QuidelOrtho Corporation, PerkinElmer Inc., QIAGEN N.V., Merck KGaA, and Fujirebio, Inc.

Key Developments:

In February 2025, Abbott and Shedd Aquarium are announcing one of Shedd's largest corporate gifts in recent history - a $10 million pledge from Abbott and Abbott's philanthropic foundation, Abbott Fund. The investment cements the longstanding partnership between Shedd, Abbott, and Abbott Fund to enrich the cultural, educational and environmental fabric of Chicago and spark passion for protecting the ocean environment.

In July 2024, Siemens Healthineers, a leading medical technology company, announced that the Multix Impact E digital radiography X-ray machine will now be manufactured in India, marking a significant milestone in the company's commitment to providing better access to care for patients in the country.

Product Types Covered:

  • Reagents & Kits
  • Analyzers
  • Software & Services
  • Other Product Types

Platforms Covered:

  • Laboratory-Based
  • Point-of-Care (POC) Testing

Technologies Covered:

  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Chemiluminescence Immunoassays (CLIA)
  • Fluorescence Immunoassays (FIA)
  • Radioimmunoassay (RIA)
  • Lateral Flow Assays
  • Others Technologies

Specimen Types Covered:

  • Blood
  • Urine
  • Saliva
  • Other Specimens

Applications Covered:

  • Infectious Diseases
  • Therapeutic Drug Monitoring
  • Oncology
  • Autoimmune Diseases
  • Cardiology
  • Endocrinology
  • Other Applications

End Users Covered:

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Blood Banks
  • Home Care Settings
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Immunoassay Market, By Product Type

  • 5.1 Introduction
  • 5.2 Reagents & Kits
    • 5.2.1 ELISA Kits
    • 5.2.2 Rapid Test Kits
    • 5.2.3 Western Blot Kits
    • 5.2.4 PCR-based Kits
  • 5.3 Analyzers
    • 5.3.1 Open-Ended Systems
    • 5.3.2 Closed-Ended Systems
  • 5.4 Software & Services
    • 5.4.1 Data Management Software
    • 5.4.2 Maintenance Services
    • 5.4.3 Validation & Custom Services
  • 5.5 Other Product Types

6 Global Immunoassay Market, By Platform

  • 6.1 Introduction
  • 6.2 Laboratory-Based
  • 6.3 Point-of-Care (POC) Testing

7 Global Immunoassay Market, By Technology

  • 7.1 Introduction
  • 7.2 Enzyme-Linked Immunosorbent Assay (ELISA)
  • 7.3 Chemiluminescence Immunoassays (CLIA)
  • 7.4 Fluorescence Immunoassays (FIA)
  • 7.5 Radioimmunoassay (RIA)
  • 7.6 Lateral Flow Assays
  • 7.7 Others Technologies

8 Global Immunoassay Market, By Specimen Type

  • 8.1 Introduction
  • 8.2 Blood
  • 8.3 Urine
  • 8.4 Saliva
  • 8.5 Other Specimens

9 Global Immunoassay Market, By Application

  • 9.1 Introduction
  • 9.2 Infectious Diseases
  • 9.3 Therapeutic Drug Monitoring
  • 9.4 Oncology
  • 9.5 Autoimmune Diseases
  • 9.6 Cardiology
  • 9.7 Endocrinology
  • 9.8 Other Applications

10 Global Immunoassay Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals & Clinics
  • 10.3 Diagnostic Laboratories
  • 10.4 Academic & Research Institutes
  • 10.5 Pharmaceutical & Biotechnology Companies
  • 10.6 Blood Banks
  • 10.7 Home Care Settings
  • 10.8 Other End Users

11 Global Immunoassay Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Abbott Laboratories
  • 13.2 F. Hoffmann-La Roche Ltd.
  • 13.3 Siemens Healthineers
  • 13.4 Danaher Corporation
  • 13.5 Thermo Fisher Scientific Inc.
  • 13.6 bioMerieux SA
  • 13.7 DiaSorin S.p.A.
  • 13.8 Becton, Dickinson and Company (BD)
  • 13.9 Sysmex Corporation
  • 13.10 Bio-Rad Laboratories, Inc.
  • 13.11 QuidelOrtho Corporation
  • 13.12 PerkinElmer Inc.
  • 13.13 QIAGEN N.V.
  • 13.14 Merck KGaA
  • 13.15 Fujirebio, Inc.

List of Tables

  • Table 1 Global Immunoassay Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Immunoassay Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Immunoassay Market Outlook, By Reagents & Kits (2024-2032) ($MN)
  • Table 4 Global Immunoassay Market Outlook, By ELISA Kits (2024-2032) ($MN)
  • Table 5 Global Immunoassay Market Outlook, By Rapid Test Kits (2024-2032) ($MN)
  • Table 6 Global Immunoassay Market Outlook, By Western Blot Kits (2024-2032) ($MN)
  • Table 7 Global Immunoassay Market Outlook, By PCR-based Kits (2024-2032) ($MN)
  • Table 8 Global Immunoassay Market Outlook, By Analyzers (2024-2032) ($MN)
  • Table 9 Global Immunoassay Market Outlook, By Open-Ended Systems (2024-2032) ($MN)
  • Table 10 Global Immunoassay Market Outlook, By Closed-Ended Systems (2024-2032) ($MN)
  • Table 11 Global Immunoassay Market Outlook, By Software & Services (2024-2032) ($MN)
  • Table 12 Global Immunoassay Market Outlook, By Data Management Software (2024-2032) ($MN)
  • Table 13 Global Immunoassay Market Outlook, By Maintenance Services (2024-2032) ($MN)
  • Table 14 Global Immunoassay Market Outlook, By Validation & Custom Services (2024-2032) ($MN)
  • Table 15 Global Immunoassay Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 16 Global Immunoassay Market Outlook, By Platform (2024-2032) ($MN)
  • Table 17 Global Immunoassay Market Outlook, By Laboratory-Based (2024-2032) ($MN)
  • Table 18 Global Immunoassay Market Outlook, By Point-of-Care (POC) Testing (2024-2032) ($MN)
  • Table 19 Global Immunoassay Market Outlook, By Technology (2024-2032) ($MN)
  • Table 20 Global Immunoassay Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2024-2032) ($MN)
  • Table 21 Global Immunoassay Market Outlook, By Chemiluminescence Immunoassays (CLIA) (2024-2032) ($MN)
  • Table 22 Global Immunoassay Market Outlook, By Fluorescence Immunoassays (FIA) (2024-2032) ($MN)
  • Table 23 Global Immunoassay Market Outlook, By Radioimmunoassay (RIA) (2024-2032) ($MN)
  • Table 24 Global Immunoassay Market Outlook, By Lateral Flow Assays (2024-2032) ($MN)
  • Table 25 Global Immunoassay Market Outlook, By Others Technologies (2024-2032) ($MN)
  • Table 26 Global Immunoassay Market Outlook, By Specimen Type (2024-2032) ($MN)
  • Table 27 Global Immunoassay Market Outlook, By Blood (2024-2032) ($MN)
  • Table 28 Global Immunoassay Market Outlook, By Urine (2024-2032) ($MN)
  • Table 29 Global Immunoassay Market Outlook, By Saliva (2024-2032) ($MN)
  • Table 30 Global Immunoassay Market Outlook, By Other Specimens (2024-2032) ($MN)
  • Table 31 Global Immunoassay Market Outlook, By Application (2024-2032) ($MN)
  • Table 32 Global Immunoassay Market Outlook, By Infectious Diseases (2024-2032) ($MN)
  • Table 33 Global Immunoassay Market Outlook, By Therapeutic Drug Monitoring (2024-2032) ($MN)
  • Table 34 Global Immunoassay Market Outlook, By Oncology (2024-2032) ($MN)
  • Table 35 Global Immunoassay Market Outlook, By Autoimmune Diseases (2024-2032) ($MN)
  • Table 36 Global Immunoassay Market Outlook, By Cardiology (2024-2032) ($MN)
  • Table 37 Global Immunoassay Market Outlook, By Endocrinology (2024-2032) ($MN)
  • Table 38 Global Immunoassay Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 39 Global Immunoassay Market Outlook, By End User (2024-2032) ($MN)
  • Table 40 Global Immunoassay Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 41 Global Immunoassay Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
  • Table 42 Global Immunoassay Market Outlook, By Academic & Research Institutes (2024-2032) ($MN)
  • Table 43 Global Immunoassay Market Outlook, By Pharmaceutical & Biotechnology Companies (2024-2032) ($MN)
  • Table 44 Global Immunoassay Market Outlook, By Blood Banks (2024-2032) ($MN)
  • Table 45 Global Immunoassay Market Outlook, By Home Care Settings (2024-2032) ($MN)
  • Table 46 Global Immunoassay Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.